Regencell Bioscience Holdings (RGC) Cash & Equivalents Growth (1y) (2021 - 2024)

Regencell Bioscience Holdings (RGC) Cash & Equivalents Growth (1y) (2021 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. Growth (1y) (Qtr)
1	Haleon	43.92 Bn	42.96 Bn	-	-
2	Teva Pharmaceutical Industries	43.19 Bn	39.53 Bn	2.15 Bn	69.13%
3	Zoetis	31.74 Bn	30.06 Bn	1.05 Bn	2.86%
4	Takeda Pharmaceutical	28.67 Bn	22.87 Bn	5.10 Bn	19.56%
5	United Therapeutics	22.22 Bn	19.56 Bn	683.80 Mn	13.19%
6	Viatris	18.71 Bn	17.83 Bn	1.46 Bn	56.51%
7	Neurocrine Biosciences	15.55 Bn	15.16 Bn	935.80 Mn	25.91%
8	Elanco Animal Health	11.80 Bn	11.27 Bn	798.00 Mn	-1.67%
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-	-4.65%
10	Regencell Bioscience Holdings	2.76 Bn	2.76 Bn	-	-

Download Data